BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18348224)

  • 1. Spiking of serum specimens with exogenous reporter peptides for mass spectrometry based protease profiling as diagnostic tool.
    Findeisen P; Peccerella T; Post S; Wenz F; Neumaier M
    Rapid Commun Mass Spectrom; 2008 Apr; 22(8):1223-9. PubMed ID: 18348224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
    Yepes D; Jacob A; Dauber M; Costina V; Hofheinz R; Neumaier M; Findeisen P
    Int J Oncol; 2011 Jul; 39(1):145-54. PubMed ID: 21503574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional protease profiling for diagnosis of malignant disease.
    Findeisen P; Neumaier M
    Proteomics Clin Appl; 2012 Jan; 6(1-2):60-78. PubMed ID: 22213637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chip-LC-MS for label-free profiling of human serum.
    Horvatovich P; Govorukhina NI; Reijmers TH; van der Zee AG; Suits F; Bischoff R
    Electrophoresis; 2007 Dec; 28(23):4493-505. PubMed ID: 18041038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of exogenous reporter peptides to serum samples before mass spectrometry-based protease profiling provides advantages over profiling of endogenous peptides.
    Findeisen P; Post S; Wenz F; Neumaier M
    Clin Chem; 2007 Oct; 53(10):1864-6. PubMed ID: 17885140
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A
    Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel peptide safety markers for exocrine pancreatic toxicity induced by cyanohydroxybutene.
    Walgren JL; Mitchell MD; Whiteley LO; Thompson DC
    Toxicol Sci; 2007 Mar; 96(1):174-83. PubMed ID: 17169978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling.
    Ehmann M; Felix K; Hartmann D; Schnölzer M; Nees M; Vorderwülbecke S; Bogumil R; Büchler MW; Friess H
    Pancreas; 2007 Mar; 34(2):205-14. PubMed ID: 17312459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
    Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
    J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method to analyze matrix-assisted laser desorption/ionization time-of-flight peptide profiling mass spectra.
    Dekker LJ; Dalebout JC; Siccama I; Jenster G; Sillevis Smitt PA; Luider TM
    Rapid Commun Mass Spectrom; 2005; 19(7):865-70. PubMed ID: 15724237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry.
    de Noo ME; Tollenaar RA; Ozalp A; Kuppen PJ; Bladergroen MR; Eilers PH; Deelder AM
    Anal Chem; 2005 Nov; 77(22):7232-41. PubMed ID: 16285670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive degradation of serum samples limits proteomic biomarker discovery.
    Ahmad S; Sundaramoorthy E; Arora R; Sen S; Karthikeyan G; Sengupta S
    Anal Biochem; 2009 Nov; 394(2):237-42. PubMed ID: 19632190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
    Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
    Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
    Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
    J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.